Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: Results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study

Lung Cancer

Volumn 74, Issue 3, 2011, Pages 462-468

  Gridelli, Cesare ^a   Ardizzoni, Andrea ^b   Barni, Sandro ^c   Crinò, Lucio ^d   Caprioli, Alberto ^e   Piazza, Elena ^f   Lorusso, Vito ^g   Barbera, Santi ^h   Zilembo, Nicoletta ⁱ   Gebbia, Vittorio ^j   Adamo, Vincenzo ^k   Pela, Riccardo ^l   Marangolo, Maurizio ^m   Morena, Raffaella ⁿ   Filippelli, Gianfranco ^o   Buscarino, Calogero ^p   Alabiso, Oscar ^q   Maione, Paolo ^a   Venturino, Paola ^r   De Marinis, Filippo ^s  

^a S G MOSCATI HOSPITAL   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

^c TREVIGLIO HOSPITAL   (Italy)

^d SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^e SPEDALI CIVILI   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g VITO FAZZI HOSPITAL   (Italy)

^h PO Mariano Santo   (Italy)

ⁱ NATIONAL CANCER INSTITUTE   (Italy)

^j LA MADDALENA CANCER CENTER   (Italy)

^k UNIVERSITY OF MESSINA   (Italy)

^l Ospedaliero C e G Mazzoni   (Italy)

^m SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

ⁿ Az Osp Busto Arsizio PO Saronno   (Italy)

^o Ospedale Civile San Francesco di Paola   (Italy)

^p UNIVERSITY OF CATANIA   (Italy)

^q MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^r ROCHE MILANO RICERCHE   (Italy)

^s SAN CAMILLO FORLANINI HOSPITAL   (Italy)

more..

Author keywords

Advanced NSCLC; Chemotherapy; Docetaxel; Erlotinib; Observational study; Pemetrexed; Platin based chemotherapy; Targeted therapy

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; ERLOTINIB; GEMCITABINE; NAVELBINE; PACLITAXEL; PEMETREXED;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BRONCHOSCOPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; DRUG CHOICE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; ITALY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MONOTHERAPY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; OBSERVATIONAL STUDY; PRIORITY JOURNAL; THORACOSCOPY; THORACOTOMY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; SURVIVAL ANALYSIS;

EID: 80755190087     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.04.011     Document Type: Article

References (23)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global statistics cancer, 2002. CA Cancer J Clin 2005, 55:74-108.
2. SEER cancer statistics review, 1975-2001 2004, National Cancer Institute, Bethesda, MD, Available at http://seer.cancer.gov/csr/1975_2001/. L.A.G. Ries, M.P. Eisner, C.L. Kosary (Eds.).
3. Sant M., Aareleid T., Berrino F. EUROCARE-3: survival of cancer patients diagnosed 1990-94' results and commentary. Ann Oncol 2003, 14(Suppl. 5):v61-v118.
4. Govindan R., Page N., Morgensztern D., Read W., Tierney R., Vlahiotis A., et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the Surveillance, Epidemiologic, and End Results database. J Clin Oncol 2006, 24:4539-4544.
5. Gridelli C., Ardizzoni A., Douillard J.Y., Hanna N., Manegold C., Perrone F., et al. Recent issues in first-line treatment of advanced non-small-cell lung cancer: results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology. Lung Cancer 2010, 68(3):319-331.
6. Schiller J.H., Harrington D., Belani C.P., Langer C., Sandler A., Krook J., et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002, 346:92-98.
7. Scagliotti G., Parikh P., von Pawel J., Biesma B., Vansteenkiste J., Manegold C., et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage NSCLC. J Clin Oncol 2008, 26:3543-3551.
8. Sandler A., Gray R., Perry M.C., Brahmer J., Schiller J.H., Dowlati A., et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006, 355:2542-2550.
9. Reck M., von Pawel J., Zatloukal, Ramlau R., Gorbounova V., Hiesh V., et al. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil. J Clin Oncol 2009, 27:1227-1234.
10. Ciuleanu T., Brodowicz T., Zielinski C., Kim J.H., Krzakowski M., Laack E., et al. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small cell lung cancer: a randomized, double-blind phase 3 study. Lancet 2009, 374(9699):1432-1440.
11. Cappuzzo F., Ciuleanu T., Stelmakh L., Cicenas S., Szczésna A., Juhasz E., et al. Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised placebo-controlled phase 3 study. Lancet Oncol 2010, 11(6):521-529.
12. Rosell R., Moran T., Queralt C., Porta R., Cardenal F., Camps C., et al. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 2009, 361:958-967.
13. Shepherd F.A., Dancey J., Ramlau R., Mattson K., Gralla R., O'Rourke M., et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol 2000, 18:2095-2103.
14. Hanna N., Shepherd F.A., Fossella F.V., Pereira J.R., De Marinis F., von Pawel J., et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004, 22:1589-1597.
15. Mok T.S., Wu Y.L., Thongprasert S., Yang C.H., Chu D.T., SaiJo N., et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009, 361:947-957.
16. Shepherd F., Rodrigues Pereira J., Ciuleanu T., Tan E.H., Hirsh V., Thongprasert S., et al. Erlotinib in previously treated non-small cell lung cancer. N Engl J Med 2005, 353:123-132.
17. Kaplan E.L., Meier P. Non parametric estimation from incomplete observation. J Am Stat Assoc 1958, 53:457-481.
18. Elderly Lung Cancer Vinorelbine Italian Study (ELVIS) Group Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 1999, 91:66-72.
19. Scagliotti G., Hanna N., Fossella F., Sugarman K., Blatter J., Peterson P., et al. The differential efficacy of pemetrexed according to NSCLC histology: a review of two phase III studies. Oncologist 2009, 14:253-263.
20. Owonikoko T.K., Ragin C.C., Belani C.P., Oton A.B., Gooding W.E., Taioli E., et al. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol 2007, 25:5570-5577.
21. Kim E.S., Hirsh V., Mok T., Socinski M.A., Gervais R., Wu Y.L., et al. Gefitinib versus docetaxel in previously treated (INTEREST): a randomized phase III trial. Lancet 2008, 372:1809-1818.
22. Pfister D.G., Johnson D.H., Azzoli C.G., Sause W., Smith T.J., Baker S., et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004, 22:330-353.
23. National Comprehensive Cancer Network - Clinical Practice Guidelines in Oncology. Non-small-cell lung cancer, http://www.nccn.org/.